| Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment G Bertolini, L Roz, P Perego, M Tortoreto, E Fontanella, L Gatti, G Pratesi, ... Proceedings of the National Academy of Sciences 106 (38), 16281-16286, 2009 | 1000 | 2009 |
| Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer N Zaffaroni, M Pennati, G Colella, P Perego, R Supino, L Gatti, S Pilotti, ... Cellular and molecular life sciences CMLS 59, 1406-1412, 2002 | 420 | 2002 |
| Overview of tumor cell chemoresistance mechanisms L Gatti, F Zunino Chemosensitivity: Volume II: In VIVO Models, Imaging, and Molecular …, 2005 | 285 | 2005 |
| A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system P Perego, C Caserini, L Gatti, N Carenini, S Romanelli, R Supino, ... Molecular pharmacology 55 (3), 528-534, 1999 | 210 | 1999 |
| Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents GL Beretta, G Cassinelli, M Pennati, V Zuco, L Gatti European journal of medicinal chemistry 142, 271-289, 2017 | 207 | 2017 |
| p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma C Lavarino, S Pilotti, M Oggionni, L Gatti, P Perego, G Bresciani, ... Journal of Clinical Oncology 18 (23), 3936-3945, 2000 | 180 | 2000 |
| Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin GL Beretta, V Benedetti, G Cossa, YGA Assaraf, E Bram, L Gatti, E Corna, ... Biochemical pharmacology 79 (8), 1108-1117, 2010 | 121 | 2010 |
| Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines P Perego, E Corna, MD Cesare, L Gatti, D Polizzi, G Pratesi, R Supino, ... Current medicinal chemistry 8 (1), 31-37, 2001 | 120 | 2001 |
| Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug G L Beretta, L Gatti, P Perego, N Zaffaroni Current medicinal chemistry 20 (12), 1541-1565, 2013 | 115 | 2013 |
| The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells P Perego, L Gatti, C Caserini, R Supino, D Colangelo, R Leone, S Spinelli, ... Journal of Inorganic Biochemistry 77 (1-2), 59-64, 1999 | 114 | 1999 |
| Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells G Cassinelli, V Zuco, L Gatti, C Lanzi, N Zaffaroni, D Colombo, P Perego Current medicinal chemistry 20 (15), 1923-1945, 2013 | 112 | 2013 |
| Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair S Manic, L Gatti, N Carenini, G Fumagalli, F Zunino, P Perego Current cancer drug targets 3 (1), 21-29, 2003 | 108 | 2003 |
| Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis G Bertolini, L D'Amico, M Moro, E Landoni, P Perego, R Miceli, L Gatti, ... Cancer research 75 (17), 3636-3649, 2015 | 96 | 2015 |
| Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and-resistant cells GL Beretta, L Gatti, S Tinelli, E Corna, D Colangelo, F Zunino, P Perego Biochemical pharmacology 68 (2), 283-291, 2004 | 84 | 2004 |
| Modulation of cell growth and cisplatin sensitivity by membrane γ-glutamyltransferase in melanoma cells M Franzini, A Corti, E Lorenzini, A Paolicchi, A Pompella, M De Cesare, ... European journal of cancer 42 (15), 2623-2630, 2006 | 82 | 2006 |
| Strategies to improve the efficacy of platinum compounds G Cossa, L Gatti, F Zunino, P Perego Current medicinal chemistry 16 (19), 2355-2365, 2009 | 81 | 2009 |
| Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment GL Beretta, G Cossa, L Gatti, F Zunino, P Perego Current medicinal chemistry 17 (15), 1500-1508, 2010 | 71 | 2010 |
| Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma M Bagnoli, GL Beretta, L Gatti, S Pilotti, P Alberti, E Tarantino, ... BioMed research international 2013, 2013 | 69 | 2013 |
| Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway G Cossa, L Gatti, G Cassinelli, C Lanzi, N Zaffaroni, P Perego Current pharmaceutical design 19 (5), 883-894, 2013 | 68 | 2013 |
| ABC transporters as potential targets for modulation of drug resistance. L Gatti, GL Beretta, G Cossa, F Zunino, P Perego Mini reviews in medicinal chemistry 9 (9), 1102-1112, 2009 | 68 | 2009 |
